XRAY: DENTSPLY SIRONA Inc. Stock

by  •  • Comments Off on XRAY: DENTSPLY SIRONA Inc. Stock

SIC 3843 – Dental Equipment and Supplies

Valuation
Market Cap ($M) 6,303.54
Enterprise Value ($M) 8,165.54
Book Value ($M) 3,294.00
Book Value / Share 15.87
Price / Book 1.91
NCAV ($M) -2,103.00
NCAV / Share -10.13
Price / NCAV -3.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.04

Liquidity (mrq)
Quick Ratio 0.95
Current Ratio 1.38

Balance Sheet (mrq) ($M)
Current Assets 1,973.00
Assets 7,370.00
Liabilities 4,076.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,965.00
Operating Income 309.00
Net Income -132.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic Rounding n/a
Earnings Per Share Basic n/a
Earnings Per Share Diluted Rounding n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 377.00
Cash from Investing -89.00
Cash from Financing -307.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 11.89 0.26
02-12 13G/A Artisan Partners Limited Partnership 6.10 -4.70
02-05 13G/A Nuance Investments, Llc 5.48 -8.21
01-29 13G/A BlackRock Inc. 6.20 -22.63

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 o TRANSITION REPORT PURSUANT TO SECTI
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-07 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 o TRANSITION REPORT
2023-08-07 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION R
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 235,741 1,022,856 23.05
2024-04-17 259,649 1,426,085 18.21
2024-04-16 390,389 2,123,667 18.38
2024-04-15 611,934 1,086,251 56.33

(click for more detail)

Similar Companies
SWAV – Shockwave Medical, Inc. TMCI – Treace Medical Concepts, Inc.
UTMD – Utah Medical Products, Inc. ZIMV – ZimVie Inc.


Financial data and stock pages provided by
Fintel.io